ABMA
CAS No. 332108-65-3
ABMA( —— )
Catalog No. M14116 CAS No. 332108-65-3
ABMA is a novel broad-spectrum inhibitor of intracellular toxins and pathogens, efficiently protects cells against various toxins and pathogens including viruses, intracellular bacteria and parasite.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 75 | In Stock |
|
| 2MG | 29 | In Stock |
|
| 5MG | 44 | In Stock |
|
| 10MG | 69 | In Stock |
|
| 25MG | 112 | In Stock |
|
| 50MG | 174 | In Stock |
|
| 100MG | 266 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 586 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameABMA
-
NoteResearch use only, not for human use.
-
Brief DescriptionABMA is a novel broad-spectrum inhibitor of intracellular toxins and pathogens, efficiently protects cells against various toxins and pathogens including viruses, intracellular bacteria and parasite.
-
DescriptionABMA is a novel broad-spectrum inhibitor of intracellular toxins and pathogens, efficiently protects cells against various toxins and pathogens including viruses, intracellular bacteria and parasite; protects mice from nasal instillation of an LD90 of ricin; provokes Rab7-positive late endosomal compartment accumulation in mammalian cells without affecting other organelles.
-
In VitroABMA protects cells against four bacterial toxins (Corynebacterium diphtheriae (DT; EC50 of 62.9 μM), Bacillus anthracis (LT), Clostridium difficile toxin B (TcdB; EC50 of 73.3μM), Clostridium sordellii lethal toxin (TcsL; EC50 of 86.7 μM)), three viruses (Ebola (EC50 of 3.3μM), rabies (EC50 of 19.4μM), dengue-4 virus ( EC50 of 8.2?μM)), two species of Chlamydiales intracellular bacteria (Simkania negevensis and Chlamydia trachomatis), and the parasite Leishmania infantum (EC50 of 7.1μM) at micromolar level.In A549 cells, ABMA treatment induces a decrease in ricin cytotoxicity with an EC50 of 3.8?μM, and a protection factor (R) at 30?μM ranging from 5 to 10. ABMA retained almost 100% of its biological activity against ricin-induced cytotoxicity up to six days.
-
In VivoAnimal Model:Pathogen-free female BALB/c mice (6 week-old) with ricin Dosage:2 mg/kg, 20 mg/kg, 200 mg/kg Administration:Intraperitoneal injection Result:A statistically significant protection according to survival curves was observed with a single ip dose of 2?mg/kg. The 20?mg/kg dose fully protected animals through to day 21. The 200?mg/kg dose resulted in 80% of protection of mice against ricin challenge with a single animal succumbing on day 15.
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number332108-65-3
-
Formula Weight350.3
-
Molecular FormulaC18H24BrNO
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (356.85 mM)
-
SMILES——
-
Chemical Name1-adamantyl (5-bromo-2-methoxybenzyl) amine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wu Y, et al. Sci Rep. 2017 Nov 14;7(1):15567.
molnova catalog
related products
-
Besifloxacin hydroch...
A fourth-generation fluoroquinolone antibiotic that exhibits a broad spectrum in vitro activity against a wide range of Gram-positive and Gram-negative ocular pathogens.
-
Solithromycin
A novel fluoroketolide with lower MICs than those of telithromycin and macrolides.
-
Kasugamycin hydrochl...
Kasugamycin hydrochloride hydrate(Ksg) specifically inhibits translation initiation of canonical but not of leaderless messenger RNAs. Ksg inhibition is thought to occur by direct competition with initiator transfer RNA.
Cart
sales@molnova.com